Aarvik Therapeutics
Fremont
About Aarvik Therapeutics
Aarvik Therapeutics combines a unique, proprietary modular platform with multiple target mechanisms to develop novel molecules with an improved therapeutic index for oncology targets. Backed by the extensive scientific research, development, and investment expertise of its founders and Board members, Aarvik Therapeutics is applying its vision and passion to create transformational benefits for cancer patients.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $11.5M
- Funding stage: Seed
- Last round: Seed (Sep 2025)
- Website: aarviktx.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Life Science, Oncology
Social Profiles
Canonical: https://fsome.com/organization/aarvik-therapeutics-4370 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.